+Search query
-Structure paper
Title | Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA. |
---|---|
Journal, issue, pages | Nat Med, Vol. 28, Page 946-957, Year 2022 |
Publish date | Dec 14, 2020 (structure data deposition date) |
![]() | Chandran, S.S. / Ma, J. / Klatt, M.G. / Dundar, F. / Bandlamudi, C. / Razavi, P. / Wen, H.Y. / Weigelt, B. / Zumbo, P. / Fu, S.N. ...Chandran, S.S. / Ma, J. / Klatt, M.G. / Dundar, F. / Bandlamudi, C. / Razavi, P. / Wen, H.Y. / Weigelt, B. / Zumbo, P. / Fu, S.N. / Banks, L.B. / Yi, F. / Vercher, E. / Etxeberria, I. / Bestman, W.D. / Da Cruz Paula, A. / Aricescu, I.S. / Drilon, A. / Betel, D. / Scheinberg, D.A. / Baker, B.M. / Klebanoff, C.A. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 1.96 - 3.11 Å |
Structure data | ![]() PDB-7l1b: ![]() PDB-7l1c: ![]() PDB-7l1d: ![]() PDB-7rrg: |
Chemicals | ![]() ChemComp-GOL: ![]() ChemComp-HOH: ![]() ChemComp-FMT: ![]() ChemComp-ACT: |
Source |
|
![]() | IMMUNE SYSTEM / peptide Major Histocompatibility complex / T cell receptor |